Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.4605
+0.0045 (0.99%)
Mar 17, 2026, 10:15 AM EDT - Market open

Gossamer Bio Revenue

Gossamer Bio had revenue of $13.29M in the quarter ending September 30, 2025, with 40.23% growth. This brings the company's revenue in the last twelve months to $44.05M, down -58.17% year-over-year. In the year 2024, Gossamer Bio had annual revenue of $114.70M.

Revenue (ttm)
$44.05M
Revenue Growth
-58.17%
P/S Ratio
2.40
Revenue / Employee
$303,800
Employees
145
Market Cap
106.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024114.70M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Agenus106.83M
Fortress Biotech62.30M
Q32 Bio53.74M
Verrica Pharmaceuticals35.58M
Seer, Inc.16.58M
Pyxis Oncology2.82M
Genelux8.00K
Revenue Rankings